MedPath

Automated Detection of Metastatic Bone Disease on Bone Scintigraphy Scans

Completed
Conditions
Metastatic Bone Tumor
Registration Number
NCT05110430
Lead Sponsor
Maastricht University
Brief Summary

Bone scintigraphy scans are two dimensional medical images that are used heavily in nuclear medicine. The scans detect changes in bone metabolism with high sensitivity, yet it lacks the specificity to underlying causes. Therefore, further imaging would be required to confirm the underlying cause. The aim of this study is to investigate whether deep learning can improve clinical decision based on bone scintigraphy scans.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2365
Inclusion Criteria
  • Patients who underwent a bone scintigraphy scan that is available with the radiologic report between 2010-2018
Exclusion Criteria
  • The lack of a bone scan, or corresponding radiologic report

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The classification performance of DL algorithm compared to the ground truthJune 2021

Reporting the performance measures (Area under the curve, accuracy, specificity..etc)

Secondary Outcome Measures
NameTimeMethod
Comparing the classification performance of the DL algorithm to that of physiciansJune 2021

Correctness of the diagnosis of Dr versus AI (dichotomous variable: correct versus not correct) on a subset of the validation data, using a McNemar statistical test

Trial Locations

Locations (1)

Maastricht University

🇳🇱

Maastricht, Limburg, Netherlands

Maastricht University
🇳🇱Maastricht, Limburg, Netherlands

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.